Legions of nanorobots target cancerous tumors with precision
Monday, August 15, 2016 - 18:01
in Health & Medicine
The legions of nanorobotic agents are actually composed of more than 100 million flagellated bacteria Researchers from Polytechnique Montréal, Université de Montréal and McGill University have just achieved a spectacular breakthrough in cancer research. They have developed new nanorobotic agents capable of navigating through the bloodstream to administer a drug with precision by specifically targeting the active cancerous cells of tumours. This way of injecting medication ensures the optimal targeting of a tumour and avoids jeopardizing the integrity of organs and surrounding healthy tissues. As a result, the drug dosage that is highly toxic for the human organism could be significantly reduced.